The proposed new icons have colour gradients, adding more depth to the layers, confirming that 3D is very much back. This ...

JPMorgan analyst Richard Shane lowered the firm’s price target on AGNC Investment (AGNC) to $8.50 from $9.50 and keeps an Overweight rating on ...

Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...